Peripheral Arthritis – Friday Pop Quiz 10/27
A 28-year-old previously healthy man presents with thick crusting and hyperkeratosis of the palms and soles, urethritis, and one month of peripheral arthritis. Which of the following is true regarding his condition?
A. Females and males are equally affected
B. About 20% of patients will have a long-term disease that results in enthesitis and destructive arthritis.
C. TNF-alpha inhibit …
A 28-year-old previously healthy man presents with thick crusting and hyperkeratosis of the palms and soles, urethritis, and one month of peripheral arthritis. Which of the following is true regarding his condition?
A. Females and males are equally affected
B. About 20% of patients will have a long-term disease that results in enthesitis and destructive arthritis.
C. TNF-alpha inhibit … Continue reading "Peripheral Arthritis – Friday Pop Quiz 10/27"
Dr. Michael J. Visconti continues our Therapeutic Cheat Sheet series, surgical edition, with a look at the bilobed flap, one of the workhorse reconstructive designs in the armamentarium of dermatologic surgeons.
The Bilobed Flap Therapeutic Cheat Sheet
Compiled by: Michael J. Visconti, DO | Reviewed by: Vishal A. Patel, MD
Background
Vascular Supply: random pattern
Movement Clas … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed to Dr. Molly Hinshaw, professor of dermatology, section chief of dermatopathology and director of the nail clinic at the University of Wisconsin School of Medicine and Public Health. Watch as Dr. Hinshaw shares her tips for performing nail biopsies. Find out what’s the safest and most usef … 
A 45-year-old female with acute myeloid leukemia was started on induction chemotherapy and developed the following eruption on the face 10 days after therapy. The patient is febrile, and CBC reveals neutropenia. What is the most common drug culprit?
A. Acylovir
B. Valcyclovir
C. Etoposide
D. Sorafenib
E. Cytarabine
To find out the correct answer and read the explanation, click … 
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …